Droplette Launches Droplette 2

Today, Droplette launched the second generation of its award-winning skincare device. The innovative, R&D-driven company continues to forge ahead, creating best-in-class products for a more connected and effective at-home beauty system.

Nurturing good skincare habits is now smarter, and easier, than ever. The technology behind Droplette 2 features optimizations across hardware, software and mobile app updates to deliver clinically-proven skincare treatments and an enjoyable individualized experience without the need to visit a medical spa. The micro-infusing device harnesses the power of fluid physics phenomena and transforms dermatologist-recommended treatment capsules (collagen, retinol, tranexamic acid, glycolic acid, lip plumper and growth factors) into a high-speed micro-mist, permeating the skin without needles or pain and achieving absorption depths of injectables, more powerfully than ever.

This evolved version of the Droplette device shares just 5% of the same internal design as the previous version, and is a literal breakthrough – painlessly delivering skincare ingredients 20x deeper past the skin barrier than topicals for clinical-grade results at home.

Features and benefits:

  • Sleeker design with a smaller charger for easy portability
  • Enhanced connectivity and expanded memory with built-in Bluetooth 5.0 technology to work smarter, not harder
  • 10-Volt Pump for stronger delivery so potent yet gentle skincare goes deeper
  • Boost preferred serum capsules with specific treatment modes to target personal skin concerns (blemishes, under-eye treatments and lip plumping)
  • Complimentary 1:1 real-time appointments with Droplette licensed estheticians for personalized recommendations and regimens

Alongside these improvements, the new Droplette retails for $199, a 33% reduction credited to more efficient design with an eye on augmenting availability to a broader customer base.

“Through continued development based on research, testing and customer feedback, we’ve created an improved Droplette device that will appeal to a wide segment of beauty product users,” said Droplette CEO and cofounder Madhavi Gavini. “The connected device leads to noticeable, lasting results, and by reducing the price we’re able to welcome more users who want to invest in their skin.”

Significant updates in the hardware are accompanied by a new and improved mobile experience. The Droplette app, which previously served simply as a way to control the device’s misting modes, has evolved to become an engaging home base for users to connect with a licensed esthetician for personalized guidance on demand, tailor their skincare routine, and track their progress over time.

“Droplette 2 is sleeker and smarter. It allows users to create even more targeted and customized treatment plans, based on their own skin goals. Now, customers have access to an end-to-end connected experience to improve their skin from within,” said CTO and cofounder Rathi Srinivas. “With a more advanced app and stronger device connectivity along with one-on-one consultations with estheticians, Droplette users have every tool at their disposal to achieve maximum results.”

The new device is available exclusively through Droplette.io and the app is available in both Apple and Android stores.

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”